Cargando…
Cannabinoid Receptor 1 Blockade Attenuates Obesity and Adipose Tissue Type 1 Inflammation Through miR-30e-5p Regulation of Delta-Like-4 in Macrophages and Consequently Downregulation of Th1 Cells
Obesity is characterized by chronic low-grade inflammation that contributes to development of cardiometabolic disorders. Cannabinoid receptor 1 (CB1) antagonists attenuate diet-induced obesity (DIO) and related inflammation, although the precise anti-inflammatory mechanisms involved have not been fu...
Autores principales: | Miranda, Kathryn, Mehrpouya-Bahrami, Pegah, Nagarkatti, Prakash S., Nagarkatti, Mitzi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523050/ https://www.ncbi.nlm.nih.gov/pubmed/31134094 http://dx.doi.org/10.3389/fimmu.2019.01049 |
Ejemplares similares
-
Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity
por: Mehrpouya-Bahrami, Pegah, et al.
Publicado: (2017) -
Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
por: Nagarkatti, Prakash, et al.
Publicado: (2020) -
AhR Activation by TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) Attenuates Pertussis Toxin-Induced Inflammatory Responses by Differential Regulation of Tregs and Th17 Cells Through Specific Targeting by microRNA
por: Al-Ghezi, Zinah Zamil, et al.
Publicado: (2019) -
Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases
por: Holloman, Bryan Latrell, et al.
Publicado: (2021) -
MicroRNA-30 modulates metabolic inflammation by regulating notch signaling in adipose tissue macrophages
por: Miranda, Kathryn, et al.
Publicado: (2018)